CXMT’s claimed tech breakthrough and an AI industry leader’s comments are weighing on stocks across the sector.
The shares are currently undervalued as the market overstates how much GLP-1 weight-loss drugs will erode demand. Sleep ...
The bottom line: Our $44 fair value estimate for no-moat Woodside is little changed. At around $31.50, the market remains ...
A subtle shift is influencing who can borrow, how much they can access and which property strategies still stack up.
Shani and Mark explore the trade-offs investors face when choosing between income, growth and different investment strategies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results